Stocktoria

JOHNSON & JOHNSON JNJ

NYSE · stock · Pharmaceutical Preparations · website · IPO 1944-09-25 · LEI

JOHNSON & JOHNSON statistics & valuation

Market cap$613.0B
P / E22.9×
P / S6.5×
P / B7.5×
P / FCF31.1×
Net margin28.5%
Return on equity32.9%
FCF margin20.9%
Net debt$21.7B
Enterprise value USD$634.8B
Graham number -65%$91.27

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($91.27); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
23.00% 1.70% 18.80% 18.40% 17.80% 26.50% 22.40% 41.30% 15.80% 28.50% 2017201720182019202120222023202320242025
Gross margin (%)
69.70% 66.70% 66.80% 66.40% 65.60% 70.30% 69.30% 68.80% 69.10% 67.90% 2017201720182019202120222023202320242025
Operating margin (%)
2017201720182019202120222023202320242025
Return on equity (%)
23.50% 2.20% 25.60% 25.40% 23.30% 28.20% 23.40% 51.10% 19.70% 32.90% 2017201720182019202120222023202320242025
Shares outstanding
2.79B 2.75B 2.73B 2.68B 2.67B 2.67B 2.66B 2.56B 2.43B 2.43B 2017201720182019202120222023202320242025
Net debt ($)
$3.47B $12.85B $9.58B $9.19B $20.45B $17.63B $15.55B $5.49B $8.29B $21.73B 2017201720182019202120222023202320242025
Share buybacks ($)
2017201720182019202120222023202320242025
Return on assets (%)
11.70% 0.80% 10.00% 9.60% 8.40% 11.50% 9.60% 21.00% 7.80% 13.50% 2017201720182019202120222023202320242025
Free cash flow margin (%)
21.60% 23.30% 22.70% 24.30% 24.40% 25.10% 21.50% 21.40% 22.30% 20.90% 2017201720182019202120222023202320242025
Debt / equity (×)
0.32× 0.51× 0.46× 0.45× 0.54× 0.43× 0.37× 0.40× 0.45× 0.51× 2017201720182019202120222023202320242025
EPS ($)
$5.93 $0.47 $5.61 $5.63 $5.51 $7.81 $6.73 $13.72 $5.79 $11.03 2017201720182019202120222023202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

JOHNSON & JOHNSON trades at about 23.7× earnings — near its 10-year norm (10-year range 11.6×–294×, median 24.3×).

11.6× 294×

Shaded band = 10-year range (11.6×–294×); dot = today's 23.7×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2023FY2022FY2021FY2019FY2018FY2017FY2017
Gross margin67.9%69.1%68.8%69.3%70.3%65.6%66.4%66.8%66.7%69.7%
Net margin28.5%15.8%41.3%22.4%26.5%17.8%18.4%18.8%1.7%23.0%
FCF margin20.9%22.3%21.4%21.5%25.1%24.4%24.3%22.7%23.3%21.6%
Return on assets13.5%7.8%21.0%9.6%11.5%8.4%9.6%10.0%0.8%11.7%
Return on equity32.9%19.7%51.1%23.4%28.2%23.3%25.4%25.6%2.2%23.5%
Debt / equity0.51×0.45×0.40×0.37×0.43×0.54×0.45×0.46×0.51×0.32×
Current ratio1.031.111.160.991.351.211.261.471.412.47

Computed from company filings · US · as of 2025-12-28. Facts plus Stocktoria's own computed scores — not investment advice.